Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Majeti

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Oncogene|November 16, 2010
Monoclonal antibody therapy directed against human acute myeloid leukemia stem cellsR Majeti
Oncogene|February 22, 2012
Clonal evolution of acute leukemia genomesM Jan, R Majeti
Leukemia|July 10, 2014
Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesisM R Corces-Zimmerman, R Majeti
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirusM Lagunoff, R Majeti, A Weiss, et al.
Molecular and Cellular Biology|March 22, 2001
Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylationJ E Baker, R Majeti, S G Tangye, et al.
Science (New York, N.Y.)|January 24, 1998
Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedgeR Majeti, A M Bilwes, J P Noel, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|August 30, 2021
EFFECT OF REOPENING ORDERS ON COVID-19 HOSPITALIZATIONS IN THE USRon N Nachum, William A Ding, Logan B Pageler, et al.
Annual Review of Medicine|January 27, 2022
Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic CellsR Majeti, C Jamieson, W W Pang, et al.
Cell|February 13, 2001
An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunityR Majeti, Z Xu, T G Parslow, et al.
Leukemia|July 24, 2013
Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomibM Huang, D Thomas, M X Li, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Oncogene|November 16, 2010
Monoclonal antibody therapy directed against human acute myeloid leukemia stem cellsR Majeti
Oncogene|February 22, 2012
Clonal evolution of acute leukemia genomesM Jan, R Majeti
Leukemia|July 10, 2014
Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesisM R Corces-Zimmerman, R Majeti
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirusM Lagunoff, R Majeti, A Weiss, et al.
Molecular and Cellular Biology|March 22, 2001
Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylationJ E Baker, R Majeti, S G Tangye, et al.
Science (New York, N.Y.)|January 24, 1998
Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedgeR Majeti, A M Bilwes, J P Noel, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|August 30, 2021
EFFECT OF REOPENING ORDERS ON COVID-19 HOSPITALIZATIONS IN THE USRon N Nachum, William A Ding, Logan B Pageler, et al.
Annual Review of Medicine|January 27, 2022
Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic CellsR Majeti, C Jamieson, W W Pang, et al.
Cell|February 13, 2001
An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunityR Majeti, Z Xu, T G Parslow, et al.
Leukemia|July 24, 2013
Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomibM Huang, D Thomas, M X Li, et al.
Pageof 2